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The origin recognition complex (ORC) in yeast is a
complex of six tightly associated subunits essential for
the initiation of DNA replication. Human ORC subunits
are nuclear in proliferating cells and in proliferative
tissues like the testis, consistent with a role of human
ORC in DNA replication. Orc2, Orc3, and Orc5 also are
detected in non-proliferating cells like cardiac myo-
cytes, adrenal cortical cells, and neurons, suggesting an
additional role of these proteins in non-proliferating
cells. Although Orc2–5 co-immunoprecipitate with each
other under mild extraction conditions, a holo complex
of the subunits is difficult to detect. When extracted
under more stringent extraction conditions, several of
the subunits co-immunoprecipitate with stoichiometric
amounts of other unidentified proteins but not with any
of the known ORC subunits. The variation in abundance
of individual ORC subunits (relative to each other) in
several tissues, expression of some subunits in non-pro-
liferating tissues, and the absence of a stoichiometric
complex of all the subunits in cell extracts indicate that
subunits of human ORC in somatic cells might have
activities independent of their role as a six subunit com-
plex involved in replication initiation. Finally, all ORC
subunits remain consistently nuclear, and Orc2 is con-
sistently phosphorylated through all stages of the cell
cycle, whereas Orc1 is selectively phosphorylated in
mitosis.
The discovery of the origin recognition complex (ORC)1 in
Saccharomyces cerevisiae was a landmark in the study of eu-
karyotic DNA replication in that it was the first sighting of the
elusive replication initiator protein in eukaryotes (1). The rep-
licon hypothesis states that most DNA replication systems will
have a replicator sequence that is part of the genome of the
organism and an initiator protein that binds to the replicator
and initiates DNA replication (2). The dnaA protein in Esche-
richia coli and the large T antigen of SV40 are among the best
studied initiators of DNA replication. In the yeast S. cerevisiae,
autonomous replication of plasmids required the presence of an
autonomously replicating sequence (ARS) consensus sequence
in the plasmid, which serves as the hypothetical replicator
element. Yeast ORC was purified from yeast extracts because
of its ability to bind to the ARS consensus sequence in a se-
quence-specific, ATP-dependent reaction, consistent with its
function as an initiator. The genes for all six subunits of yeast
ORC (named ORC1 to ORC6) were cloned and shown to be
essential for viability (3–8). Temperature-sensitive mutants in
several of the ORC subunits arrested with a cell cycle stage-
specific block, consistent with a role of the complex in DNA
replication. A recombinant protein complex composed of all six
yeast subunits was prepared in insect cells and shown to be a
weak ATPase that binds to the 11-base pair ARS consensus
sequence (9).
Homologs of the yeast ORC subunits have been identified in
several higher eukaryotes. In Xenopus egg extracts, a complex
of proteins containing known homologs of yeast ORC subunits
was shown by immunodepletion to be essential for DNA repli-
cation (10–13). This experimental system was used to demon-
strate that a critical function of Xenopus ORC is in the recruit-
ment of the CDC6 protein to chromatin, which then permits the
recruitment of minichromosome maintenance (MCM) proteins.
A complex of six proteins was identified in Drosophila embryo
extracts containing all six homologs of yeast ORC that sup-
ported DNA replication in vitro (14–16). The genes for at least
two of these Drosophila subunits are essential for viability (16,
17). In a tissue-specific gene amplification event in Drosophila
ovarian follicle cells, Drosophila Orc2 co-localizes to the sites of
gene amplification and binds to some of the sequences required
for the amplification process (18). Overall, this large body of
work provides convincing evidence that, as in yeast, ORC from
higher organisms is a multi-subunit protein complex that
serves as the initiator protein to recognize putative replicator
elements in the genome and initiate DNA replication.
With the aim of understanding the initiation of DNA repli-
cation in mammalian somatic cells, we (17, 20, 21) and several
others (19, 22, 23) identify five of the human homologs of the six
yeast ORC subunits based on sequence similarity and associa-
tion with known ORC subunits. Orc6 is poorly conserved in
amino acid sequence between S. cerevisiae, Schizosaccharomy-
ces pombe, and Drosophila (24) and is dispensable both for the
formation of a multi-subunit complex and for sequence specific
DNA binding in S. cerevisiae (25).
Given the central role of the six subunit ORC in the initiation
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of DNA replication, it is important to examine the status of this
complex in the mammalian somatic cells that give rise to cell
proliferative diseases like cancers. All studies on the biochem-
istry of ORC have utilized cells that either proliferate rapidly
or have the potential to do so, e.g. yeast cells, Drosophila
embryo extracts, or Xenopus egg extracts. In this paper we
examine for the first time the biochemical and cell biological
properties of human ORC in somatic cells that proliferate at a
far slower rate than the special cases utilized to date and come
to the conclusion that a tight complex containing all subunits of
ORC is difficult to detect in these cells. In addition, individual
ORC subunits are selectively expressed in certain non-prolif-
erating tissues, suggesting that isolated ORC subunits might
have functions unrelated to replication initiation. Even in pro-
liferating cells in culture several of the ORC subunits are
associated with unique proteins that are not the other known
ORC subunits, raising the possibility that either there are
more than six ORC subunits in mammalian cells or that some
of the subunits are in complexes unrelated to DNA replication
initiation.
EXPERIMENTAL PROCEDURES
Cell Culture—Culture conditions for human HeLa, U2OS, and 293T
cells as well as conditions for cell cycle synchronization with nocodazole
and hydroxyurea have been described previously (20). For metabolic
labeling with [35S]methionine, cells were incubated for 2 h in medium
lacking methionine and then incubated overnight in medium supple-
mented to a final concentration of 3 mM cold methionine plus 200 mCi
(34 pM) of [35S]methionine (PerkinElmer Life Sciences, 1175 Ci/mmol).
For in vivo labeling with [32P]orthophosphate, cells were incubated in
phosphate-free medium for 2 h and then in medium containing 350 mCi
(80 pM) of [32P]orthophosphate (PerkinElmer Life Sciences, 8500 Ci/
mmol) for another 4 h before harvesting.
RNA Analysis—Northern blots containing RNA from 16 adult hu-
man tissues were obtained commercially (CLONTECH), and hybridiza-
tions using 32P-labeled cDNA probes were performed as suggested by
the manufacturer. Blots were washed at 42 °C in 0.13 SSC, 0.1% SDS
and exposed to film at 280 °C with an intensifying screen. Northern
analysis of HeLa cells has been described previously (20).
Protein Analysis—Western blots containing 75 mg protein/lane from
a panel of 9 tissues were obtained commercially (Geno Technology, Inc.)
and immunoblotted with anti-ORC antibodies as directed by the man-
ufacturer. Cell extracts were prepared in ice-cold RIPA buffer (150 mM
NaCl, 50 mM Tris, pH 8, 1% Nonidet P-40, 0.5% deoxycholate, 0.1%
SDS) containing 50 mM NaF, 1 mM Na3VO4, 0.1 mM phenylmethylsul-
fonyl fluoride, 10 units of DNase, 100 mg/ml RNase A, and 1 mg/ml each
pepstatin A, leupeptin, and aprotinin. Lysates were precleared by in-
cubation with pre- or non-immune antibody and protein A-Sepharose
beads for 1 h, and the supernatants were transferred to new tubes
before immunoprecipitation with specific antibodies. The beads were
washed four times in RIPA buffer before the addition of sample buffer.
For denaturation-immunoprecipitation experiments, immunoprecipi-
tates were boiled in 1% SDS for 10 min, then diluted 10-fold in RIPA
buffer that did not contain SDS and immunoprecipitated again.
Antibodies to Orc2, Orc3, Orc4, and Orc5 have been published (17,
20, 21, 26). Anti-Orc1 antibody was raised in rabbits (Cocalico Biologi-
cals) against a bacterially expressed recombinant His6-tagged fragment
of Orc1 from amino acids 579–861 created by cloning into the NdeI and
BamHI sites of pET14.b.
Gel Filtration Methods—5 3 106 293T cells were extracted in 0.1%
Nonidet P-40 lysis buffer (50 mM Tris, pH 8.0, 0.1% Nonidet P-40, 150
mM NaCl, 50 mM NaF, 1 mM Na3VO4, 5 mM EDTA, 2 mM dithiothreitol,
1 mM phenylmethylsulfonyl fluoride, 2 mg/ml pepstatin A, 2 mg/ml
leupeptin, and 5 mg/ml aprotinin) for 1 h at 4 °C. The lysate was
centrifuged (15,000 3 g for 20 min at 4 °C), and the clear lysate was
filtered through a 0.22-mm filter. The filtrate was subjected to fast
protein liquid chromatography Superose 12 (Amersham Pharmacia Bio-
tech) gel filtration column chromatography using lysis buffer at a flow
rate of 0.2 ml/min. Alternate fractions were separated on 12% SDS-
polyacrylamide gels and immunoblotted with anti-ORC antibodies.
Immunostaining—For immunohistochemistry, 4-mm-thick paraffin
sections of formalin-fixed tissue were used after deparaffinization and
rehydration (27). Sections were blocked for 15 min at room temperature
with 1.5% goat serum in PBS and then incubated with primary anti-
body at room temperature for 1 h in a humid chamber. Antibodies used
were anti-Orc3 and anti-Orc5, with matched pre-immune sera. After
rinsing with phosphate-buffered saline, sections incubated with anti-
Orc5 or matched pre-immune serum were processed with the Vec-
tastain Elite ABC Kit (Vector Laboratories, Inc.) as specified by the
manufacturer and developed using 3,39- diaminobenzidine (Sigma) as
substrate. Sections incubated with anti-Orc3 or matched pre-immune
serum were processed with the Vectastain ABC alkaline phosphatase
kit (Vector Laboratories, Inc.) as specified by the manufacturer and
developed using Vector alkaline phosphatase substrate kit I (Vector
Red).
For immunofluorescence, U2OS cells were transfected with vectors
expressing T7-tagged Orc1. For analysis of Orc2-Orc5, untransfected
HeLa (Orc2 and Orc5) or U2OS (Orc3 and Orc4) cells were used.
General conditions for immunofluorescence have been described previ-
ously (26) except that for Orc3 analysis, cells were fixed and permeabi-
lized for 2 min at room temperature in a 1:1 (v:v) methanol:acetone
solution.
RESULTS
Expression of ORC mRNAs in Human Tissues—In every
cultured human cell line we have examined to date (17, 20, 21,
26) all ORC subunits (Orc1–5) are expressed at reasonably
high levels. To study ORC expression in normal human tissues,
Northern blots of a panel of 16 tissues were hybridized sequen-
tially with cDNA probes specific for Orc1-Orc5 (Fig. 1). Multi-
ple RNA species were not observed; rather, a single transcript
of the size predicted by the full-length cDNA was observed for
each ORC subunit. The results suggest that the mRNA of
individual ORC subunits are sometimes expressed in non-pro-
FIG. 1. Expression of ORC mRNAs
in human tissues. cDNA probes specific
for Orc1-Orc5, glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH), and b-ac-
tin were hybridized sequentially to North-
ern blots (CLONTECH) of poly(A)1
mRNA from indicated tissues (peripheral
blood leukocyte (PBL). Glyceraldehyde-3-
phosphate dehydrogenase and b-actin are
references of the amount of RNA loaded in
each lane. HeLa, Northern blot of total
RNA purified from asynchronously grow-
ing HeLa cells to demonstrate mRNA lev-
els of ORC subunits in tissue culture cells.
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liferating tissues that do not always express all the other
known subunits.
Orc1 expression alone correlated with the level of tissue
proliferation. Highest levels of Orc1 mRNA were observed in
tissues with high proliferative activity such as testis and colon
mucosal lining. Orc1 mRNA is also high in a tissue like the
placenta, which would have proliferated rapidly in its recent
history and is moderately expressed in the thymus with prolif-
erating T lymphocytes (after correcting for slight underloading
of mRNA from the latter). Orc1 mRNA essentially is undetect-
able in primarily non-proliferating tissues such as heart, brain,
lung, liver, skeletal muscle, kidney, spleen, prostate, ovary,
small intestine, and peripheral blood leukocyte. The mRNA
from the small intestine was obtained from the entire thickness
of the gut and so was not enriched in the proliferating cells of
the mucosa. Therefore, Orc1 mRNA levels reflect the prolifer-
ative activity in tissues consistent with regulation of Orc1
expression by the E2F transcription factor (28).
In contrast, mRNA levels of the other ORC subunits (Orc2–5)
were not dependent on the proliferative activity in the tissue.
As observed with Orc1, Orc2–5 are expressed at high levels in
testis. However, high levels of Orc2–5 were observed in tissues
with low proliferation such as heart, pancreas, and ovary.
Intermediate expression of Orc2–5 was seen in brain, placenta,
skeletal muscle, and kidney. The levels of Orc2–5 mRNA are
high in heart and skeletal muscle even after the signal inten-
sity is adjusted to reflect overloading (as judged from the con-
trol b-actin and glyceraldehyde-3-phosphate dehydrogenase
probes).
In several tissues, only a subset of ORC subunits are ex-
pressed at significant levels. In lung, Orc3 and Orc4 mRNA are
seen, whereas Orc2 and Orc5 mRNA are virtually absent. In
thymus, only Orc1 and Orc5 show measurable levels, whereas
in the small intestine only Orc5 exhibits a faint band. In all
tissues the control b-actin and glyceraldehyde-3-phosphate de-
hydrogenase probes yield strong signals, suggesting that the
low level of ORC subunit signal in some tissues is not due to
drastic sample underloading.
In addition, note that even in proliferating tissues expressing
Orc1, signal ratios between various ORC subunits are not
constant. For example, thymus expresses Orc1 at much higher
levels than Orc2–4, and Orc1 is expressed at a higher level
than Orc2 in colonic mucosa. In testis, however, Orc1 appears
underexpressed relative to most of the other subunits.
ORC Subunit Proteins Are Expressed in Non-proliferating
Human Tissue—Since analysis of ORC subunit RNA levels in
normal tissue suggested that abundance of transcripts does not
correlate strictly with proliferation status, we investigated
whether the same held true at the protein level. A commer-
cially obtained blot containing protein from normal human
tissue was immunoblotted sequentially with polyclonal anti-
sera specific for Orc1-Orc5 (Fig. 2). Ponceau S staining of total
proteins on the blot indicated that the brain extract was sig-
nificantly underloaded. Orc1 is nearly undetectable in non-
proliferating tissues, consistent with its mRNA being seen
exclusively in proliferating tissues. Very low levels of Orc1 are
observed in kidney and spleen when the immunoblot is over-
exposed. The approximately 90-kDa protein detected in heart
also is recognized by pre-immune serum, and thus, we do not
believe it to be Orc1. Orc 2–4 also were detected in testis. The
absence of Orc5 in the testis extract is explained by our earlier
observation that Orc5 is associated with the nuclear matrix of
cultured proliferating cells (21) and is expected to be extracted
poorly under the conditions used to prepare these tissue sam-
ples. Immunohistochemistry (see below) indeed confirms that
Orc5 protein also is abundant in the testis. Thus, a proliferat-
ing tissue like the testis contains all ORC subunit proteins.
Several non-proliferating tissues, however, expressed sub-
sets of ORC subunits. A 70-kDa Orc2 protein was detected in
non-proliferating tissues like pancreas, liver, brain, kidney,
ovary, and heart. An 80-kDa Orc3 protein was also detected in
non-proliferating tissues like the heart, but the levels in other
non-proliferating tissues did not correlate with that of the
mRNA. For example, non-proliferating tissues like pancreas,
spleen, and ovary expressed Orc3 mRNA (Fig. 1), but the pro-
tein was undetectable (Fig. 2), suggesting regulation of expres-
sion at the post-transcriptional level. Orc4 protein of approxi-
mately the correct size (45 kDa) was detected in testis and at
least three non-proliferating tissues (lung, kidney, and heart),
consistent with the presence of Orc4 mRNA in these tissues.
Orc5 was detected in extracts from two non-proliferating
tissues: brain and heart. In our hands Orc5 is poorly extracted
from proliferating cells using conditions other than 8 M urea,
and therefore, the lack of protein in the testis lane probably
reflects poor extraction from proliferating cells. The ease of
extraction of Orc5 from non-proliferating tissues like the brain
and heart, on the other hand, is most likely because the protein
is not in a holo complex interacting with the DNA replication
machinery. We had earlier reported that the ORC5 locus pro-
duces an alternatively spliced mRNA that codes for an ORC5T
protein containing the N-terminal two-thirds of Orc5 and a
unique cytoplasmic tail of 31 amino acids (21). Specific anti-
ORC5T antibody raised against this unique C-terminal peptide
confirmed that the extractable Orc5 protein from brain and
heart is not ORC5T (data not shown).
Slight variations in the size of ORC protein subunits in some
FIG. 2. ORC subunit proteins in non-proliferating cells. Com-
mercial Western blot (Geno Technology, Inc.) containing 75 mg of total
protein lysate from indicated tissues immunoblotted with anti-ORC
antibodies. The Ponceau S stain indicates that the brain lane is under-
loaded. Anti-Orc2 and anti-Orc5 antibodies were affinity-purified
against appropriate recombinant proteins, whereas anti-Orc1, anti-
Orc3, and anti-Orc4 antisera were used directly. The left half of the
anti-Orc1 panel is overexposed to show the low levels of Orc1 present in
kidney and spleen. HeLa cells, HeLa cell lysates separated on 12%
SDS-polyacrylamide gels and immunoblotted with anti-ORC antibodies
to show the approximate size of authentic ORC subunits. Since Orc1 is
extracted poorly in RIPA buffer, it was immunoprecipitated from ly-
sates with anti-Orc1 antibody before electrophoresis and immunoblot-
ting. The band in the heart lane marked with an asterisk in the
anti-Orc4 panel is not an Orc4-specific protein. It is a residual 45-kDa
band that persisted from an earlier probing with anti-Orc2 antibody.
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tissues are most likely due to tissue-specific post-translation
modifications. For example, the Orc1 protein in the testis and
spleen is about 20 kDa larger than the protein in HeLa cells or
in the kidney. Orc2 in the liver is about 5-kDa larger that in
other tissues. The Orc4 protein exhibits mobility shifts of 2–4
kDa in various tissues. In all cases, the bands shown in the
figure were the sole polypeptides detected upon immunoblot-
ting with the relevant antibody (in addition, the anti-Orc2 and
anti-Orc4 antibodies had been affinity-purified on recombinant
Orc2 or Orc4), leading us to believe that these reactions are
specific and recognize either the authentic ORC subunit or a
closely related variant. In addition, to eliminate cross-reactive
proteins we immunoblotted with the relevant pre-immune con-
trol antisera (data not shown).
Besides small variations in the sizes of some of the ORC
subunits there were two instances with a large variation in the
size of the detected protein in a given tissue. A variant protein
of 45 kDa reacted with the anti-Orc2 antibody in heart lysates.
Similarly, brain expressed a 47-kDa protein that reacted
strongly with the anti-Orc3 antibody (instead of the expected
80-kDa Orc3 protein). In both these instances, the cognate
mRNA was abundant (Orc2 in heart and Orc3 in brain), so that
one hypothesis is that the variant proteins are the products of
alternatively spliced mRNA (as we have shown with ORC5T
(21)). We cannot, however, rule out cross-reaction of the anti-
body to an unrelated tissue-specific protein.
ORC Localization in Tissues by Immunohistochemistry—The
abundance of ORC subunit proteins in tissues that have not
proliferated in decades such as heart and brain raise the pos-
sibility that the subunits are expressed by infiltrating cells
from the blood rather than the non-proliferating cardiac myo-
cytes or neurons. Immunohistochemistry on sections of tissues
is another method by which one can confirm the presence of a
protein and determine the specific cells expressing the protein
of interest. Conditions for immunohistochemistry on paraffin
sections were established using sections of testis as positive
controls (Fig. 3). The anti-Orc3 and anti-Orc5 antibodies were
the only antibodies that gave positive results on these sections,
with pre-immune sera giving negative results. Positive stain-
ing with two out of the five antibodies tried is a reasonable
success rate for immunohistochemistry on paraffin sections. In
testis, with its high level of cell proliferation, both Orc3 and
Orc5 proteins were detected in the nuclei of proliferating germ
cells.
Orc3 protein is present in the nucleus of non-proliferating
cells in at least three tissues: heart (myocytes), tonsil (lympho-
cytes outside germinal center), and adrenal (epithelial cells)
(Fig. 4). We believe that the anti-Orc3 antibody stains Orc3
protein in the tissue section for the following reasons. In all
tissues examined, the pre-immune serum exhibited no back-
ground staining in the nucleus. Of the tissues on the immuno-
blots (Fig. 2), nuclear staining with anti-Orc3 antibody was
detected only in the testis and the heart (Figs. 3 and 4), the two
tissues with an 80-kDa Orc3 protein. Tissues on the blot that
did not have the 80-kDa protein (liver, brain, lung, kidney,
spleen, and pancreas) did not show nuclear staining with anti-
Orc3 antibody (not shown). Based on this correlation we are
most certain that nuclear staining in paraffin sections with
anti-Orc3 antibody detects the authentic 80-kDa Orc3 protein.
Despite the expression of Orc3 mRNA in brain, kidney, spleen,
and pancreas, the Orc3 protein is undetectable in these tissues
by two independent methods (immunoblot and immunohisto-
chemistry) confirming that the expression must be regulated at
the post-transcriptional level. The 47-kDa protein detected by
the anti-Orc3 antibody in immunoblots of brain extracts (Fig.
2) was not detected by immunostaining (not shown), indicating
that epitopes recognized by the anti-Orc3 antibody in paraffin
sections are not present in the 47-kDa variant.
Anti-Orc5 antibody recognized a nuclear protein in the testis,
cardiac myocytes, brain, and tonsils, whereas the pre-immune
serum gave negative results (Figs. 3 and 4). As discussed ear-
lier, Orc5 protein is difficult to extract from proliferating cells
in culture, so we were not surprised by the lack of correlation
with the immunoblot from testis. The presence of Orc5 protein
in cardiac myocytes was confirmed by two independent means
(immunoblot and immunostaining). Anti-Orc5 antibody recog-
nized the protein in extracts of brain but stained granules in
the cytoplasmic compartment of neurons (Fig. 4). This result is
consistent with our suggestion that ease of extraction of Orc5
FIG. 3. Nuclear localization of ORC in proliferating cells of the
testis. Paraffin sections of normal testis were used for immunohisto-
chemical analysis with anti-Orc5 (a) or anti-Orc3 (c) antibodies or with
matched pre-immune control serum (b) and (d). Orc5 antibodies were
detected with 3,39- diaminobenzidine (stains brown), whereas Orc3
antibodies were detected with alkaline phosphatase (stains red). Nuclei
were counterstained with hematoxylin (stains blue). Images were pho-
tographed at 2003.
FIG. 4. Localization of ORC in non-proliferating tissues. A,
immunohistochemical analysis of heart, adrenal gland, and tonsil par-
affin sections with anti-Orc3 antibody (a–c) or matched pre-immune
control serum (d–f) as described in Fig. 3. B, immunohistochemical
analysis of heart, brain, and tonsil paraffin sections with anti-Orc5
antibody (g–i) or matched pre-immune (Pre-imm.) control serum (j–l) as
described in Fig. 3. i and l were photographed at 803. Representative
positive staining in (a, b, g, and h) is indicated by arrowheads.
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from certain tissues might indicate a role of the protein in
something other than DNA replication.
Several Cellular Proteins That Are Not Known ORC Sub-
units Associate with Individual ORC Subunits with High Af-
finity—Previous immunoprecipitation/immunoblotting experi-
ments indicate that several of the human ORC subunits from
somatic cells can associate with each other under gentle extrac-
tion conditions (0.1% Nonidet P-40, 150 mM NaCl), especially
when overexpressed (17, 19–21). Such experiments do not,
however, reveal whether other cellular proteins are tightly
associated with the ORC subunits. To examine this question,
HeLa cells were metabolically labeled with [35S]methionine
and the ORC subunits immunoprecipitated after extraction in
RIPA buffer, a relatively stringent buffer that sustains only
high affinity interactions (Fig. 5A, top). Similar immunopre-
cipitates from unlabeled cell extracts were immunoblotted with
the various anti-ORC subunit antibodies (Fig. 5A, bottom).
We note first that the metabolically labeled, extractable,
Orc1 (100 kDa) protein appears not to be associated with the
other ORC subunits but is co-precipitated with unknown pro-
teins of .200, 150, 80, 45, and 30 kDa (Fig. 5A, top). Immuno-
blotting shows that none of the associated proteins are recog-
nized by antibodies to the other ORC subunits (Fig. 5A,
bottom). Conversely, immunoprecipitation with anti-Orc2, an-
ti-Orc3, and anti-Orc4 consistently failed to co-immunoprecipi-
tate a band of 100 kDa that could be Orc1. Immunoblotting of
these precipitates with anti-Orc1 antibody confirmed that Orc1
was not co-immunoprecipitated. We confirmed the recent re-
port that the bulk of Orc1 is not extracted from cells even under
RIPA buffer lysis conditions (29). Therefore the newly synthe-
sized Orc1 that is extracted in Fig. 5A is most likely a sub-
population that is not yet in the holo-ORC bound to DNA but is
still tightly associated with cellular proteins that are not
known ORC subunits.
Under similar stringent conditions anti-Orc2 antiserum co-
immunoprecipitated the 70-kDa Orc2 protein with several cel-
lular proteins, only two of which were known ORC subunits:
Orc3 and Orc5. The anti-Orc2 immunoprecipitate can be com-
pared with the three other pre-immune lanes in Fig. 5A (non-
immune controls). In addition, we have previously shown that
the matched pre-immune serum (which is no longer available)
did not immunoprecipitate any metabolically labeled protein
from human cell extracts (20). Besides Orc2 (70 kDa) anti-Orc2
co-precipitated another protein of roughly the same size. The
latter protein is Orc3 (Fig. 5A, bottom), which runs at 70 kDa
under these gel conditions, suggesting that endogenous Orc2
and Orc3 remain associated with each other in RIPA buffer
conditions. Peptide digestion and ion trap mass spectrometry of
the 48-kDa polypeptide in the Orc2 immunoprecipitate identi-
fied this protein as Orc5.2 Because of interference from the
50-kDa IgH band in the immunoprecipitate in Fig. 5A, anti-
Orc2 antibody cross-linked to protein A-Sepharose beads was
used to immunoprecipitate Orc2 so that the precipitate could
be blotted with anti-Orc5 antibody (Fig. 5B). A 48-kDa Orc5
protein is detected in the Orc2 immunoprecipitate, indicating
that although the bulk of the cellular Orc5 protein can be
extracted only with 8 M urea (21), a fraction of it is extracted
from cells in RIPA buffer in a complex with Orc2. In contrast to
Orc3 and Orc5, Orc4 (45 kDa) did not remain associated with
Orc2 in RIPA buffer conditions (Fig. 5A, bottom). The 45-kDa
metabolically labeled protein that co-immunoprecipitates with
Orc2 is not recognized by the anti-Orc4 antiserum and is an
unidentified protein. In summary, under RIPA extraction con-
ditions Orc2 is co-immunoprecipitated with Orc3 and Orc5 but
not with Orc1 or Orc4. Several other proteins present in the
Orc2 immunoprecipitate in RIPA buffer conditions (180, 170,
145, 130, 120, 85, and multiple bands of 70 kDa and 45 kDa) do
not correspond to known ORC subunits.
Immunoprecipitation with anti-Orc3 antibody precipitates
Orc3 (runs as 70 kDa under these gel conditions). Immunoblot-
ting confirms that Orc2 (also 70 kDa) is co-precipitated (Fig.
5A, bottom) but not Orc1 nor Orc4. Additional proteins are
detected, however, corresponding to sizes of 200, 160, 120, 85,
and 33 kDa (Fig. 5A, top). Again, none of these proteins corre-
spond to known ORC subunits.
Anti-Orc4 antibody immunoprecipitates Orc4 (45 kDa) and
associated proteins of 150, 52, and 30 kDa. Co-immuno-
precipitation of Orc2 and Orc3 (both of 70 kDa) or Orc1
(100 kDa) is not observed under these extraction conditions
(Fig. 5A, bottom). Our anti-Orc5 antibody cannot be used for
immunoprecipitation.
For each anti-ORC subunit antibody, denaturation of the
immunoprecipitates in SDS followed by re-immunoprecipita-
2 S. Dhar, A. Dutta, and W. S. Lane, unpublished information.
FIG. 5. ORC subunits associate with additional cellular pro-
teins. A, top, [35S]methionine-labeled HeLa cell lysates were immuno-
precipitated with antibodies against Orc1-Orc4 or with matched pre-
immune serum (PI). Note that there is no Orc2 pre-immune and that
the three other pre-immune lanes may be used as a non-immune con-
trol. Immunoprecipitated proteins were separated on 12% SDS-poly-
acrylamide gels and visualized by fluorography. Expected migration of
Orcs1–5 is indicated by arrowheads. Bands at 150, 85, and 30 kDa as
well as those indicated with dots are discussed in the text. M, molecular
weight markers. Bottom, unlabeled HeLa lysates were immunoprecipi-
tated with anti-Orc antibodies as in A, and the precipitates were im-
munoblotted with anti-Orc antibodies (indicated on the side). Input, 5%
of lysate used for each immunoprecipitation. B, Orc5 associates with
Orc2. 293T cell lysate was immunoprecipitated using anti-Orc2 anti-
bodies (I) or pre-immune sera (PI) followed by immunoblotting using
anti-Orc2 or anti-Orc5 antibodies. 5% of lysate used for pre-immune
serum was loaded in the input (Inp.) lanes.
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tion selectively precipitated the subunit recognized by the an-
tibody and none of the other polypeptides present in the pri-
mary immunoprecipitate (data not shown). Therefore the other
polypeptides are precipitated by virtue of their association with
the ORC subunit and not due to cross-reaction with the anti-
bodies. The proteins of 150 kDa (Fig. 5A, Anti-Orc1 and Anti-
Orc4 lanes), 85 kDa (Anti-Orc2, anti-Orc3, and faint bands in
Anti-Orc4 and Anti-Orc1 lanes), and 30 kDa (Anti-Orc1 and
Anti-Orc4 lanes) are three unknown proteins that consistently
are associated with more than one known ORC subunit and
could be bona fide members of the human ORC holo complex.
The other polypeptides appear to be uniquely associated with
individual ORC subunits and either are components of mam-
malian ORC that are stably bound to the complex through only
one of the known subunits or truly interact with only one of the
subunits in functions different from that of the six subunit
holo-ORC.
Under RIPA buffer conditions, detectable amounts of Orc2,
Orc3, and Orc5 remain associated with each other. Under less
stringent conditions Orc4 associates with this complex (17). As
of yet, we have not been able to find conditions where Orc1 is
extracted and remains associated with a complex of the other
ORC subunits. This arrangement of the human ORC subunits,
where Orc2, 3, 4, and 5 form a sub-complex that is not depend-
ent on the association of Orc1, is remarkably similar to that
suggested for the yeast ORC subunits (25).
Most of Cellular Orc2–5 Are Not Associated with Each Other
in a Single Complex—Under gentle conditions for lysis (150 mM
NaCl, 0.1% Nonidet P-40) that preserve inter-subunit interac-
tions, only a small fraction of Orc1 is extracted (29). Despite the
absence of Orc1, the remaining subunits (Orc2–5) extracted
under gentle lysis conditions co-immunoprecipitate with each
other (17, 20, 21). Co-immunoprecipitation experiments detect
sub-stoichiometric associations between proteins but do not
examine whether most of the extracted Orc2–5 exist in a com-
plex containing all four subunits. To address this question, a
HeLa cell extract (150 mM NaCl, 0.1% Nonidet P-40) was frac-
tionated on a gel filtration column, and the fractions were
immunoblotted with antibodies to individual ORC subunits
(Fig. 6). Orc2 (70 kDa) and Orc3 (80 kDa) both elute as approx-
imately 300-kDa complexes. Orc4 (45 kDa) peaked at about 100
kDa, whereas Orc5 (50 kDa) peaked at about 50 kDa. Together
with the robust co-immunoprecipitation of Orc2 and Orc3, the
co-elution of the two proteins suggest that they exist in cells
mostly complexed with each other. The size of the complex (300
kDa) is slightly larger than expected for a 1:1 complex of Orc2
(70 kDa) and Orc3 (80 kDa). Further experiments are needed to
assess whether the complex contains more than one subunit
each of Orc2 and Orc3 or whether other cellular proteins (which
might include sub-stoichiometric amounts of Orc4 and Orc5)
are associated with them. Similarly, a small fraction of Orc4
and Orc5 may be in a complex of about 100 kDa, or the Orc4
may be in a complex with itself or an unknown protein. Thus,
although Orc2–5 co-immunoprecipitate with each other (17, 20,
21), we conclude that even under gentle extraction conditions
only a small fraction of Orc2–5 is likely to be associated with
each other in a single complex. Thus if a soluble heteropentam-
eric or heterohexameric ORC exists, it must do so at a level
below the threshold of detectability in Fig. 6. Whether this
weak association of the subunits is due to the absence of Orc1
in the extract or describes the natural state of ORC subunits in
mammalian somatic cells is not clear.
Immunofluorescence of ORC Subunits in Cells—We and oth-
ers have reported changes in subcellular localization of CDC6
protein based on the position of the cell in the cell cycle (26,
30–32). CDC6 is in the nucleus in G1 and is displaced to the
cytoplasm in S phase such that in a culture of asynchronous
cells the protein is detected in the nucleus in some cells and in
the cytoplasm in others (Fig. 7). We can now examine the
behavior of the ORC complex by immunofluorescence of asyn-
chronous cells in culture. Affinity-purified antibodies to Orc2,
Orc3, and Orc4 and anti-Orc5 antiserum each detected a single
polypeptide upon immunoblotting extracts from cultured cells
and detected the endogenous protein by immunofluorescence.
Antibodies to Orc2 recognized a nuclear protein detectable
throughout the nucleus but also concentrated in fine dots (Fig.
7, A and B). The nature of these dots is unclear. Orc2 was never
detected in the cytoplasm. Antibodies to Orc3, Orc4, and Orc5
also recognized exclusively nuclear proteins. Anti-Orc5 anti-
body detected a protein with exclusively nuclear localization,
which however, was like Orc2 in being distributed throughout
the nucleus but also concentrated in discrete sub-nuclear foci
(Fig. 7, A and B).
Antibodies to Orc1 did not give a positive result when used
for immunofluorescence experiments, so epitope-tagged Orc1
protein (T7-Orc1) was expressed in cells by transfection, and
the protein was detected by anti-T7 antibody. Untransfected
cells served as negative controls. T7-Orc1 was detected only in
the nucleus of asynchronously growing, transfected cells.
Thus, all the ORC subunits examined appeared to be in the
nucleus in proliferating cells in culture regardless of their
position in the cell cycle, suggesting that the subcellular
changes in the localization of CDC6 occur independent of ORC.
Phosphorylation of ORC Subunits in Proliferating Cells—
Several cell cycle-regulated proteins are regulated by phospho-
rylation. For example, phosphorylation of cyclin E leads to its
destruction, whereas cdk2 phosphorylation either activates or
inactivates kinase activity (33, 34). Among the replication ini-
tiation factors, the phosphorylation of CDC6 by cdks is respon-
sible for the displacement of the protein from the nucleus to the
cytoplasm at the G1-S transition (30–32).
3
To examine whether any ORC subunits were phosphorylated
in vivo, asynchronously growing HeLa cells were metabolically
labeled with [32P]orthophosphate, and proteins were extracted
in RIPA buffer and immunoprecipitated with antibodies to
Orc1-Orc4. A 70-kDa phosphoprotein was present in the anti-
Orc2 immunoprecipitate, but nothing was detected in the anti-
Orc1, anti-Orc3, or anti-Orc4 immunoprecipitates (Fig. 8, left).
Treatment with phosphatase removed all label from the Orc2,
indicating that the label was due to phosphorylation (data not
shown). To confirm that the 70-kDa phosphoprotein was in fact
Orc2 and not merely an Orc2-associated protein, anti-Orc2
antibody was used to immunoprecipitate 32P-labeled cell ex-
tracts denatured by boiling in SDS. The phosphoprotein was
still immunoprecipitated by anti-Orc2. In addition, when these
3 L. Delmolino and A. Dutta, unpublished information.
FIG. 6. Association of ORC subunits (Orc2–5) in human cell
lysate. 293T cell extract was fractionated over a fast protein liquid
chromatography Superose 12 gel filtration column. Alternate fractions
were immunoblotted using anti-Orc2, 3, 4, and 5 antibodies. Fraction
numbers (11–33) are shown. Input (Inp.) lanes were loaded with 5% of
the total lysate passed through the column. The positions of the molec-
ular mass markers thyroglobulin (670 kDa), bovine gamma globulin
(158 kDa), chicken ovalbumin (44 kDa), and equine myoglobin (17 kDa)
are indicated.
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immunoprecipitates were transferred to nitrocellulose and im-
munoblotted with anti-Orc2 antibodies, the radiolabeled and
chemiluminescent 70-kDa bands were coincident. We therefore
conclude that the 70-kDa phosphoprotein is Orc2.
Consistent with the stable association of Orc2 with Orc3,
immunoprecipitation with anti-Orc3 is expected to co-precipi-
tate the 70-kDa phospho-Orc2. However, since most of the Orc2
in the cell is not associated with Orc3 in RIPA buffer (see Fig.
5A, bottom), we needed to immunoprecipitate Orc3 from 0.1%
Nonidet P-40, 150 mM NaCl lysis buffer to visualize the co-
immunoprecipitated 70-kDa phospho-Orc2 protein (Fig. 8,
right).
To determine whether any of the ORC subunits were phos-
phorylated in any one phase of the cell cycle such that the
phosphorylation was missed in the asynchronous cell extracts,
cells were blocked in S and M phase (with hydroxyurea and
nocodazole) and labeled with [32P]orthophosphate. These stud-
ies revealed that Orc2 was phosphorylated in both S and M
phases of the cell cycle but did not indicate that any of the other
ORC subunits were phosphoproteins. During the course of this
work another group reported that Orc1 is phosphorylated (as
measured by mobility shift) during the M phase of the cell cycle
(29). Treatment with phosphatase eliminated the mobility
shift. Using conditions suitable for Orc1 extraction (500 mM
NaCl), we have confirmed by direct immunoblotting of the
extracts that Orc1 is phosphorylated in M phase, as measured
by mobility shift (data not shown). We were, however, not able
to isolate 32P-labeled Orc1, but this could be explained by the
fact that the isoform of Orc1 with slower mobility is poorly
extracted and poorly immunoprecipitated with our antibody.
DISCUSSION
In higher eukaryotes, the origin recognition complex has
been studied in very early developmental stages with unusual
cell cycles: Xenopus egg extracts and Drosophila embryo ex-
tracts. In both these cases the cells are super-enriched in ini-
tiator protein factors in preparation for the very rapid S phases
that occur during early embryonic stages of life, and the results
are consistent in that all of the ORC subunits are in a stable
complex required for DNA replication.
This report is the first paper to collectively examine five ORC
subunits in mammalian somatic cells. The dominant theme
that emerges is that, contrary to the situation in yeast or in
early developmental stages, a holo complex of all ORC subunits
FIG. 7. A, ORC subunits are essentially
nuclear in cultured cells. Asynchronously
growing U2OS cells (or U2OS cells trans-
fected 48 h earlier with a plasmid ex-
pressing T7-tagged Orc1 or HA-tagged
CDC6) attached to coverslips were fixed
and incubated with anti-T7 or anti-HA
antibody or with anti-ORC antibodies (or
pre-immune control serum) followed by
fluorescein isothiocyanate (FITC)-conju-
gated swine anti-rabbit antiserum. Anti-
bodies recognizing Orc2-Orc4 were affini-
ty-purified against recombinant protein.
After washing, coverslips were mounted
with Vectashield containing 4,6-dia-
midino-2-phenylindole (DAPI) and visual-
ized under a fluorescence microscope.
Note that slight background staining ob-
served with anti-Orc3 pre-immune con-
trol is strictly cytoplasmic. B, a higher
magnification view of one cell stained ei-
ther with anti-Orc2 or with anti-Orc5 an-
tibodies to demonstrate the punctate sub-
nuclear foci of staining.
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is not easy to detect in mammalian somatic cells. Some of the
difficulty might be due to technical problems in extracting
Orc1, resulting in the breaking apart of the six subunit com-
plex. In addition, Orc2, Orc3, Orc4, and Orc5 proteins are
detected in several tissues that have very few proliferating
cells. The abundance of these subunits are not strictly corre-
lated with each other, and none of these non-proliferating tis-
sues contain Orc1 mRNA and protein. Even in proliferating
cultured cells individual ORC subunits are associated more
tightly with unidentified non-ORC polypeptides than with
known ORC subunits. Based on this, we conclude that unlike
the situation in yeast, Drosophila embryos, or Xenopus eggs, in
human somatic cells if the individual ORC subunits are in a
tight holo complex containing all subunits, then such a complex
is either not soluble or present in extracts at a level below the
threshold of detectability in Fig. 6.
Faced with the overwhelming evidence that ORC acts as a
holo complex in replication initiation in yeast, Xenopus eggs,
and Drosophila embryos, we are not proposing that this is not
the case in mammalian somatic cells. Instead, we propose that
such a complex is formed in proliferating cells but only during
a small window of time in the cell cycle or in a sub-nuclear
fraction that is difficult to extract in lysates. The co-precipita-
tion and gel filtration experiments in 0.1% Nonidet P-40 buffer
indicate that at least a sub-complex of Orc2, Orc3, Orc4, and
Orc5 can be detected in cell extracts. In addition several of the
ORC subunits are detected in non-proliferating cells. Upon
induction of the cell cycle, Orc1 is expressed from an E2F-
regulated promoter (28). The newly synthesized Orc1 is better
extracted than mature Orc1 but is not associated with other
ORC subunits (Fig. 5A). We speculate that the new Orc1 pro-
tein subsequently associates with the other ORC subunits
(most likely in a cellular fraction that is tightly associated with
the chromatin) and renders ORC competent for initiating DNA
replication. This suggestion is consistent with a recent report
that in Chinese hamster ovary cells Orc2 remains firmly asso-
ciated with chromatin in all phases of the cell cycle, whereas
Orc1 selectively associates with chromatin in G1, thereby mak-
ing the origins competent to replicate (35).
In several tissues the levels of mRNA and protein for indi-
vidual ORC subunits do not appear to correlate (Figs. 1 and 2).
For example, kidney and spleen do not contain detectable levels
of Orc1 mRNA yet express low levels of Orc1 protein, and Orc2
protein is observed in liver in the absence of detectable Orc2
mRNA. Similarly, Orc3 mRNA is detectable in kidney and
spleen, but no Orc3 protein is detected in these tissues. There
are several explanations of these apparent discrepancies. First,
the Northern and Western tissue blots were obtained from
different sources, and thus, the tissue samples are not identi-
cal. Second, the stability of individual ORC subunit mRNA and
polypeptides may vary between tissues. Particularly stable
ORC subunit proteins could be produced from exceedingly low
levels of mRNA not detectable by our analysis. Future studies
should address this issue. Finally, the ease of extractability of
individual ORC subunit proteins may vary between tissues.
These results do, however, suggest that both mRNA and pro-
tein should be examined when studying expression of a given
gene.
We reported earlier that an alternatively spliced variant of
Orc5 results in the expression of a truncated Orc5 subunit
(ORC5T) that does not encode the C-terminal one-third of the
protein (21). Here we note the existence of a 47-kDa protein in
brain that reacts to anti-Orc3 antibody and a 45-kDa protein in
heart that reacts to anti-Orc2 antibody that are different in size
from the authentic subunits seen in proliferating cells. These
could be tissue-specific proteins that fortuitously cross-react
with the antibodies but could also be tissue-specific ORC sub-
units produced by alternative splicing or post-translational
processing and might indicate a role of these subunits in spe-
cialized tissue-specific functions.
Several ORC subunits associate with several cellular
polypeptides with a higher affinity than with known ORC
subunits. The unknown cellular proteins might be involved in
DNA replication, indicating that ORC in somatic cells is a
much larger protein complex than the six-subunit complex
identified in other organisms. Alternatively, the other proteins
might be involved in recruiting ORC subunits to functions
other than initiation of DNA replication. For example, Dro-
sophila Orc3 (Latheo) has been implicated in learning (17, 36,
37). Flies with a hypomorphic mutation in Latheo have a
smaller than normal mushroom body (a portion of the fly brain)
and demonstrate defects in synaptic transmission and defects
in learning. Although the small size of the mushroom body can
be explained by a role of Orc3 in cell proliferation, the defects in
synaptic transmission implicate Orc3 in a function independ-
ent of cell proliferation. Similarly Drosophila Orc2 associates
with HP1 and decorates the heterochromatin of flies (38). Mu-
tations in Orc2 result in defects in chromatin structure, as
indicated by suppression of position effect variegation. In yeast,
ORC has been implicated in transcriptional silencing (39).
These results with Drosophila and yeast ORC lead us to sus-
pect that the unique polypeptides associated with human ORC
subunits are explained by a role of these subunits in functions
other than replication initiation. Identification of the associ-
ated proteins will help determine whether this is indeed the
case.
Regulation of replication initiation in the cell cycle could
involve changes in phosphorylation or sub-cellular localization
of ORC subunits. Our results, however, do not support such a
point of view. In asynchronously proliferating cells in culture,
no changes were detected in the sub-cellular localization of the
ORC subunits. Similarly, no changes were detected in the
phosphorylation state of the Orc2, 3, 4, and 5 subunits in the
various stages of the cell cycle. As reported, Orc1 is phospho-
rylated in M phase, but the significance of this modification is
unclear (29).
This is the first report of the status of ORC subunits in
proliferating somatic cells and in non-proliferating tissues. The
results indicate that unlike what has been so elegantly dem-
FIG. 8. Orc2 is phosphorylated in vivo. Left, lysates from asyn-
chronously growing, 32P-labeled HeLa cells were immunoprecipitated
with anti-ORC antibodies or matched pre-immune (PI) control serum
exactly as in Fig. 5A. Right, lysate from HeLa cells grown and labeled
as in the left panel but extracted in 0.1% Nonidet P-40, 150 mM NaCl
and immunoprecipitated with anti-Orc3 or matched pre-immune se-
rum. All proteins were separated on 12% SDS-polyacrylamide gels and
visualized by autoradiography.
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onstrated in yeast, Drosophila and Xenopus, a holo complex of
just six ORC subunits is difficult to extract from mammalian
somatic cells. Instead, sub-complexes of ORC exist in non-
proliferating cells, which may become competent replication
initiators only upon the appearance of Orc1 and its association
with the other subunits in a chromatin-associated sub-nuclear
fraction. In addition a study of the associated proteins and of
the expression of individual subunits in non-proliferating cells
suggests that ORC might have additional components in mam-
malian somatic cells and that ORC subunits might be recruited
to other functions not directly related to initiation of DNA
replication.
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